Please assess the completion status of the following clinical trial:

Trial Title: Long-Term Follow-Up Study of Patients Receiving ATL001

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients must have given written informed consent to participate in the study.~2. Patients must have received ATL001 in a previous Clinical Trial.~3. Patients must be considered, in the opinion of the Investigator, capable of complying with the protocol requirements.~Exclusion Criteria:~There are no exclusion criteria.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental: ATL001 (Type: OTHER): Patients who have previously received ATL001 in a clinical trial will be evaluated in this trial for long-term safety and clinical activity.
- Patients who have previously received ATL001 in study ATX-NS-001 or study ATX-ME-001 (Type: OTHER): Patients who have previously received ATL001 in study ATX-NS-001 or study ATX-ME-001

Based on this trial design, predict the completion outcome and termination type (if applicable).